Wollenweber, T.; Zisser, L.; Kretschmer-Chott, E.; Weber, M.; Grubmüller, B.; Kramer, G.; Shariat, S.F.; Mitterhauser, M.; Schmitl, S.; Vraka, C.;
et al. Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Curr. Oncol. 2021, 28, 3692-3704.
https://doi.org/10.3390/curroncol28050315
AMA Style
Wollenweber T, Zisser L, Kretschmer-Chott E, Weber M, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Schmitl S, Vraka C,
et al. Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Current Oncology. 2021; 28(5):3692-3704.
https://doi.org/10.3390/curroncol28050315
Chicago/Turabian Style
Wollenweber, Tim, Lucia Zisser, Elisabeth Kretschmer-Chott, Michael Weber, Bernhard Grubmüller, Gero Kramer, Shahrokh F. Shariat, Markus Mitterhauser, Stefan Schmitl, Chrysoula Vraka,
and et al. 2021. "Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer" Current Oncology 28, no. 5: 3692-3704.
https://doi.org/10.3390/curroncol28050315
APA Style
Wollenweber, T., Zisser, L., Kretschmer-Chott, E., Weber, M., Grubmüller, B., Kramer, G., Shariat, S. F., Mitterhauser, M., Schmitl, S., Vraka, C., Haug, A. R., Hacker, M., Hartenbach, M., & Rasul, S.
(2021). Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Current Oncology, 28(5), 3692-3704.
https://doi.org/10.3390/curroncol28050315